Expression of Concern: Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression (Mol Cell Biol., (2000), 20, (5), (1723–1732), 10.1128/mcb.20.5.1723-1732.2000);Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression

Molecular and Cellular Biology

Volumn 20, Issue 5, 2000, Pages 1723-1732

  Lee, Sam W ^a   Reimer, Corinne L ^a   Fang, Li ^b   Iruela Arispe, M Luisa ^c   Aaronson, Stuart A ^b  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; KINASE ASSOCIATED PHOSPHATASE; PHOSPHATASE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; CELL CYCLE S PHASE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0033969884     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00088-19     Document Type: Erratum

References (52)

1. Band, V., and R. Sager. 1990. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci. USA 84:1249-1253.
2. Bernardino, J., C. A. Bourgeois, M. Muleris, A. M. Dutrillaux, B. Malfoy, and B. Dutrillaux. 1997. Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization. Cancer Genet. Cytogenet. 96:123-128.
3. Brown, N., M. Noble, A. Lawrie, M. C. Morris, P. Tunnah, G. Divita, L. N. Johnson, and J. A. Endicott. 1999. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J. Biol. Chem. 174:8746-8756.
4. Carson, J. P., G. Kulik, and M. J. Weber. 1999. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3′-kinase and Ak1/protein kinase B. Cancer Res. 59: 1449-1453.
5. Charbonneau, H., N. K. Tonks, S. Kumar, C. D. Diltz, M. Harrylock, D. E. Cool, E. G. Krebs, E. H. Fischer, and K. A. Walsh. 1989. Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc. Natl. Acad. Sci. USA 86:5252-5256.
6. Charbonneau, H., and N. K. Tonks. 1992. 1002 protein phosphatases? Annu. Rev. Cell Biol. 8:463-493.
7. Cheney, I. W., D. E. Johnson, M. T. Vaillancourt, J. Avazini, A. Morimoto, G. W. Demers, K. N. Wills, P. W. Shabram, J. B. Bolen, S. V. Tavtigian, and R. Bookstein. 1998. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58:2331-2334.
8. Demetrick, D. J., S. Matsumoto, G. J. Hannon, K. Okamoto, Y. Xiong, H. Zhang, and D. H. Beach. 1995. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C(CCNC), cyclin E (CCNE). p21 (CDKN1) and KAP (CDKN3). Cytogenet. Cell Genet. 69:190-192.
9. Denu, J. M., M. A. Stuckey, M. Saper, and J. E. Dixon. 1996. Form and function in protein dephosphorylation. Cell 87:361-364.
10. Di Cristofano, A., B. Pesce, C. Cordon-Cardo, and P. P. Pandolfi. 1988. Pten is essential for embryonic development and tumor suppression. Nat. Genet. 19:348-355.
11. Draetta, G. F. 1994. Mammalian G1 cyclins. Curr. Opin. Cell Biol. 6:842-846.
12. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:817-825.
13. Ethier, S. P., M. L. Mahacek, W. J. Gullick, T. S. Frank, and B. L. Weber. 1993. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 53:627-635.
14. Furnari, F. B., H. Lin, H. S. Huang, and W. K. Cavenee. 1997. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA 94:12479-12484.
15. Galaktionov, K., and D. Beach. 1991. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 67:1181-1194.
16. Galaktionov, K., A. K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach. 1995. CDC25 phosphatases as potential human oncogenes. Science 269:1575-1577.
17. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell cycle phosphatase as a target of c-myc. Nature 382:511-517.
18. Gasparotto, D., R. Maestro, S. Piccinin, T. Vukosavljevic, L. Barzan, S. Sulfaro, and M. Boiocchi. 1997. Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res. 57:2366-2368.
19. Gilladoga, A. D., S. Edelhoff, E. M. Blackwood, R. N. Eisenman, and C. M. Disteche. 1992. Mapping of MAX to human chromosome 14 and mouse chromosome 12 by in situ hybridization. Oncogene 7:1249-1251.
20. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
21. Guan, K., R. J. Deschenes, H. Qiu, and J. E. Dixon. 1991. Cloning and expression of a yeast protein tyrosine phosphatase. J. Biol. Chem. 266: 12964-12970.
22. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1994. Cdil, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75:791-803.
23. Hammond, S. L., R. C. Ham, and M. R. Stampfer. 1984. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA 81:5435-5439.
24. Hannon, G. J., D. Casso, and D. Beach. 1994. KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc. Natl Acad. Sci. USA 91:1731-1735.
25. Harper, J. W., G. R. Adami, N. Wei, K. Keomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
26. Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821-1828.
27. Hopkin, K. 1998. A surprising function for the PTEN tumor suppressor. Science 282:1027-1030.
28. Hunter, T., and J. Pines. 1994. Cyclins and cancer. Cell 79:573-582.
29. Hunter, T. 1995. Protein kinases and phosphatases. The yin and yang of protein phosphorylation and signaling. Cell 80:225-236.
30. Jacks, T., and R. A. Weinberg. 1998. The expanding role of cell cycle regulators. Science 280:1035-1036.
31. Kinzler, K. W., and B. Vogelstein. 1998. Landscaping the cancer terrain. Science 280:1036-1037.
32. Leake, R. 1996. The cell cycle and regulation of cancer cell growth. Ann. N. Y. Acad. Sci. 784:252-262.
33. Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Pue, C. Miliaresis, L. Rogers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler, and R. Parsons. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275:1943-1947.
34. Liang, P., and A. B. Pardee. 1992. Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science 257:967-971.
35. Mungre, S., K. Enderle, B. Turk, A. Porras, Y. Wu, M. C. Mumby, and K. Rundell. 1994. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small t antigen in vitro decrease viral transformation. J. Virol. 68:1675-1681.
36. Neel, B. G., and N. K. Tonks. 1997. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9:193-204.
37. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
38. Pallas, D., L. K. Shahrik, B. L. Martin, S. Jasper, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle t antigens and sv40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
39. Parsons, R. 1998. Phosphatases and tumorigenesis. Curr. Opin. Oncol. 10: 88-91.
40. Plutzky, J., B. Neel, and R. D. Rosenberg. 1992. Isolation of a src homology 2-containing tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 89:1123-1127.
41. Poon, R. Y. C., and T. Hunter. 1995. Dephosphorylation of Cdk2 thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science 270:90-93.
42. Robertson, G. P., F. B. Furnari, M. E. Miele, M. J. Glendening, D. R. Welch, J. W. Fountain, T. G. Lugo, H. J. Huang, and W. K. Cavenee. 1998. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc. Natl. Acad. Sci. USA 95:9418-9423.
43. Roulston, D., R. Espinosa, G. Nucifora, R. A. Larson, M. M. Le Beau, and J. D. Rowley. 1998. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92: 2879-2885.
44. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
45. Sontag, E., S. Federov, C. Kamibayashi, D. Robbins, M. Cobb, and M. Mumby. 1993. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75:887-897.
46. Strauss, M., J. Lukas, and J. Bartek. 1995. Unrestricted cell cycling and cancer. Nat. Med. 1:1245-1246.
47. Tamura, M., J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K. M. Yamada. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617.
48. Cas. Cancer Res. 59:442-449.
49. Tonks, N. K., and B. G. Neel. 1996. From form to function: signaling by protein tyrosine phosphatases. Cell 87:365-368.
50. Turc-Carel, C., P. Dal Cin, L. Boghosian, J. Terk-Zakarian, and A. A. Sandberg. 1988. Consistent breakpoints in region 14q22-q24 in uterine leiomyoma. Cancer Genet. Cytogenet. 32:25-31.
51. Wu, X., K. Senechal, N. S. Neshat, Y. E. Whang, and C. L. Sawyers. 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95:15587-15591.
52. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kohayashi, and D. Beach, 1993. p21 is a universal inhibitor of cyclin kinases. Nature 66:701-704.